It has also directed the regulators to initiate a special campaign to weed out any objectionable advertisement with respect to misleading claims of the drugs displayed on prominent public places, he said.
Hussan Lal, Secretary Health cum Commissioner, Food and Drugs Administration (FDA) said this here while presiding over meeting of State Drugs Advisory Committee, he said.
Lal directed the officials to make sure that no objectionable material is highlighted in either print media or electronic media through advertisements or any promotional messages.
The drugs regulatory officers were also directed to launch the mass campaign with immediate effect and to submit their progress report till December 31, 2014 and to effectively deal with the violators.
Tightening the grip on the chemists indulged in trading of habit-forming drugs, Lal said that no leniency in this matter would be tolerated by the government.
The drugs inspectors were asked to fast-track the checking of the chemists to ensure that no person shall indulge in unethical trade of habit-forming drugs and further to ensure attendance of registered pharmacist on the retail sale shops.
Thermolabile refers to a substance which is subject to destruction or decomposition or change in response to heat.
"Whosoever found not maintaining the cold chain; 'such licensees' shall not be allowed to stock such drugs under the currency of their licences and shall be de-barred to stock such drugs," he said.
Lal further said that the zonal licensing authorities have been asked to initiate strict action against the retail sale chemists where the pharmacist remains absent.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
